About this episode
The episode discusses the implications of the Trump administration's rescheduling of medical cannabis and its potential effects on the industry.
What are the impacts of the Trump administration’s rescheduling of state-licensed medical cannabis to Schedule III from Schedule I? Could federal rescheduling extend to recreational marijuana later this year? If so, how should companies, firms and operators prepare for a world where significant tax relief and growth opportunities emerge? Would Congress face pressure to consider a federal tax on the budding sector if broader cannabis reform is in the cards? Foley Hoag Partner Jeffrey Schultz joins Bloomberg Intelligence’s Nathan Dean and Holly Froum on this episode of the Votes and Verdicts podcast to discuss these and other questions facing the industry. See omnystudio.com/listener for privacy information.
People in this episode
Hosts: Nathan Dean, Holly Froum
Guest: Jeffrey Schultz
Topics covered
- marijuana rescheduling
- medical cannabis
- federal tax
- cannabis reform
- business opportunities
- Trump administration
Keywords
- marijuana
- cannabis
- Schedule III
- Schedule I
- federal rescheduling
- tax relief
- growth opportunities
- Congress
- recreational marijuana
Mentioned in this episode
Organizations: Trump administration, Foley Hoag, Bloomberg Intelligence
More episodes of Votes & Verdicts
- Bayer Appeal of Roundup Suits at Supreme Court · June 5, 2026 · 29 min
- Social Media Addicts, Seed Antitrust, AI Tax · May 29, 2026 · 27 min
- Joyce Adetutu on Tariff Risks, Refunds · May 22, 2026 · 25 min
- Can Trump Fix the Housing Affordability Pinch? · May 15, 2026 · 44 min
- Why Mortgage Rates Are Stuck Above 6% · May 8, 2026 · 50 min
- Proposed Ban on Institutional Home Ownership · May 5, 2026 · 40 min
Explore listener stats, chart rankings, contacts and more on the Votes & Verdicts podcast page.